MicroRNAs in diagnosis of ovarian cancer. Potential, Challenges, Pitfalls

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10320336" target="_blank" >RIV/00216208:11110/15:10320336 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

MicroRNAs in diagnosis of ovarian cancer. Potential, Challenges, Pitfalls

Popis výsledku v původním jazyce

Ovarian cancer is the most deadly gynecological cancer. High mortality of the patients is usually associated with the progression of the disease. Most of the patients are diagnosed within the advanced stages due to lacking relevant diagnostic and screening markers. Achieving the diagnosis in the early stages of disease is a prerequisite of the more successful treatment of ovarian cancer. In this review, we focus on the recent progress in research focused on circulating, particularly cell-free microRNAsexpression in diagnostically relevant samples such as blood, plasma/serum and urine. More research will be needed to establish circulating and extracellular microRNAs as the novel diagnostic markers for ovarian cancer.

Název v anglickém jazyce

MicroRNAs in diagnosis of ovarian cancer. Potential, Challenges, Pitfalls

Popis výsledku anglicky

Ovarian cancer is the most deadly gynecological cancer. High mortality of the patients is usually associated with the progression of the disease. Most of the patients are diagnosed within the advanced stages due to lacking relevant diagnostic and screening markers. Achieving the diagnosis in the early stages of disease is a prerequisite of the more successful treatment of ovarian cancer. In this review, we focus on the recent progress in research focused on circulating, particularly cell-free microRNAsexpression in diagnostically relevant samples such as blood, plasma/serum and urine. More research will be needed to establish circulating and extracellular microRNAs as the novel diagnostic markers for ovarian cancer.

Druh

C - Kapitola v odborné knize

CEP obor

EB - Genetika a molekulární biologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

Handbook on Ovarian Cancer: Risk Factors, Therapies and Prognosis

ISBN

978-1-63483-925-9

Počet stran výsledku

18

Strana od-do

45-62

Počet stran knihy

247

Název nakladatele

Nova Science Publishers

Místo vydání

New York

Kód UT WoS kapitoly

—